We are pleased to announce that on December 11, 2024, a meeting regarding the opening of the Centers was held at the Bielański Hospital in Warsaw as part of the clinical trial carried out at LBBK "Assessment of the safety and effectiveness of an advanced therapy medicinal product containing live ASC cells in the treatment of diabetic foot syndrome - study double-blind, randomized (Acronym: FootCell).” The meeting was attended by representatives of all Parties involved in the Project: National Coordinator of the clinical trial, prof. PhD. Beata Mrozikiewicz-Rakowska, Principal Investigators: prof. PhD. Wojciech Zgliczyński from the Bielański Hospital and prof. PhD. Leszek Czupryniak from UCK WUM, Members of Research Teams and representatives of LBBK. The meeting agenda included, among others: discussion of the principles of Good Clinical Practice (GCP) in the context of the conducted study, reminder of study plans and procedures and the requirements for keeping study documentation.